Markets
5.5
AEX Hits Record Close Despite Tech Weakness; Defensives Lead
Published 17 h ago2 sourcesEvidence: Reported
SeverityModerateFDLow-rated sourceNL
Investor anxiety in biotech is rising due to underlying, unspecified pressures beyond headline volatility. The piece signals a structural shift in sentiment rather than a single event, with implications for sector valuations and capital flows.
Locations
Entities
Published 17 h ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 17 h ago1 sourceEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported
Published 1 d ago9 sourcesEvidence: Reported
Published 2 d ago8 sourcesEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported